Saad Mahmood

Dr Mahmood's research focus is on cardiotoxicity of oncology immunotherapy such as immune checkpoint inhibitors, and he is principal investigator of a multi-center chimeric antigen receptor T-cell therapy registry.  He is System Director of Cardio-Oncology at St Francis Heart Center and Catholic Health Services of Long Island, which under his leadership has been awarded Gold status ‘Center of Excellence’ designation by the International Cardio-Oncology Society. 

Prior to that he was founder/Interim Director of Cardio-Oncology Program at Weill Cornell Medicine, and has previously been on faculty at Harvard Medical School and Memorial Sloan Kettering Cancer Center. He completed internal medicine residency at Massachusetts General Hospital (MGH), Harvard Medical School, and his cardiovascular disease fellowship at Weill Cornell Medicine where he was chief fellow. He also completed a two-year Cardio-Oncology fellowship at MGH and Brigham and Women's Hospital (heart failure section). He is a graduate of Case Western medical school.